voltarol 100mg suppositories
novartis pharmaceuticals uk ltd - diclofenac sodium - suppository - 100mg
voltarol 100mg suppositories
dowelhurst ltd - diclofenac sodium - suppository - 100mg
voltarol 100mg suppositories
de pharmaceuticals - diclofenac sodium - suppository - 100mg
voltarol 100mg suppositories
sigma pharmaceuticals plc - diclofenac sodium - suppository - 100mg
voltarol 100mg suppositories
lexon (uk) ltd - diclofenac sodium - suppository - 100mg
voltarol 100mg suppositories
stephar (u.k.) ltd - diclofenac sodium - suppository - 100mg
voltarol 100mg suppositories
necessity supplies ltd - diclofenac sodium - suppository - 100mg
voltarol 100mg suppositories
waymade healthcare plc - diclofenac sodium - suppository - 100mg
diclofenac sodium- diclofenac sodium tablet, delayed release
bluepoint laboratories - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 25 mg - carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets, usp and other treatment options before deciding to use diclofenac sodium delayed-release tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). diclofenac sodium delayed-release tablets, usp, are indicated: diclofenac sodium delayed-release tablets, are contraindicated in patients with known hypersensitivity to diclofenac. diclofenac sodium delayed-release tablets should not be given to patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings: anaphylactic reactions and precautions: preexisting asthma ). diclofenac sodium delayed-release tablets are contraindicated in the setting of coronary artery bypass graft (cabg) surgery (see warnings ).
diclofenac sodium- diclofenac sodium gel
remedyrepack inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 30 mg in 1 g - diclofenac sodium gel, 3% is indicated for the topical treatment of actinic keratoses (ak). sun avoidance is indicated during therapy. diclofenac sodium gel, 3% is contraindicated in patients with a known hypersensitivity to diclofenac, benzyl alcohol and/or polyethylene glycol monomethyl ether 350. diclofenac sodium gel, 3% is contraindicated in the following patients: - in the setting of coronary artery bypass graft (cabg) surgery.